Pharmacologic Treatment for PTSD and Opioid Use Disorders
$6.00 | CE Hours:2.00 | Intermediate
CE Course Description
Individuals with co-occurring mental and substance use disorders (COD) are common in behavioral health and primary health settings. These individuals frequently benefit from pharmacologic interventions, whether for mental disorders, substance use disorders, or both. As a companion to the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) General Principles for the Use of Pharmacological Agents to Treat Individuals with Co-Occurring Mental and Substance Use Disorders, this document provides guidelines for pharmacologic interventions for individuals with PTSD and co-occurring opioid use disorders.
CE Course Objectives
1. Describe the prevalence of PTSD in adults in the United States, as well as the co-occurrence of PTSD and substance use disorders.
2. Outline various psychosocial and pharmacologic interventions for treating PTSD in individuals with opioid disorders.
3. Identify the use of specific medications to treat PTSD and opioid dependence.
4. Discuss polysubstance abuse in those with opioid dependence and PTSD.
Date Added: 2013-02-11
Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degree of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.
*Board Approvals for this course can be found here.
*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at: email@example.com.